Dr. Sclafani, it's been about 7 months that you have been back performing procedures, and I think by your own estimates, you've performed a couple hundred procedures(?), many repeat procedures using innovative and untested treatment methods.
eric, i do not think that untested treatment methods is an accurate or fair statement. Everything that i have described is a well accepted treatment. For example, balloon angioplasty of valves is well known and accepted. Rendevous procedures have been done for quite some time. I would agree that these well tested treatment methods have been used in innovative ways to overcome some obstacles.
Could you tell us generally how your patients have done following treatment using your specialized approach,
whether you continue to see occlusions, clots, etc.,
I have not yet seen an occlusion since i have redefined the angioplasty endpoints by using IVUS and dilating to a balloon diameter that has a cross sectional area that is 1.5-2 times the cross sectional area of the vein surrounding the stenosis and better standardized my anticoagulation regimen.
and whether results are better, positive and enduring compared to what we understand to be the "1/3's" grouping of results and Dr. Zamboni's stats on re-stenosis.
i have not seen any results that speak about 1/3 groupings of results. Besides, it would be difficult to understand that or compare that without knowing EDSS, duration of symptoms, classification of MS, and many other variables. That said, i can generalize to say that outcomes remain unpredictable, some patients do very well, some have great improvements, others have modest improvements, others still have no improvements and an occasional patient gets worse.
Of course, long term outcomes are not really possible to discern yet.
I haven't seen a steady stream of good, enduring testimonials from your patients in spite of your presentations of individual case studies and your identification of discrete lesions that might have otherwise been missed and your change in treatment methods.
I cannot speak about testimonials. I have difficulty interpreting them.
Are you seeing trends that you can share of your patients' results that might help us all understand how your approach is now working in terms of actual impact on patient health beyond improved blood flow?
Not really. too many variables and too short a followup.